Statistically, high expression of EphA2 was found to be significantly correlated with tumor size (P = 0.0416), lymph node metastasis (P = 0.018), lymphovascular invasion (P = 0.013), and TNM stage (P = 0.035). The gene discussed is EPHA2; the disease is neoplasm.